Search Results

There are 4958 results for: content related to: Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients

  1. You have free access to this content
    Antibody Mediated Rejection Associated With Complement Factor H–Related Protein 3/1 Deficiency Successfully Treated With Eculizumab

    American Journal of Transplantation

    Volume 12, Issue 9, September 2012, Pages: 2546–2553, D. Noone, J. Al-Matrafi, K. Tinckam, P. F. Zipfel, A. M. Herzenberg, P. S. Thorner, F. G. Pluthero, W. H. A. Kahr, G. Filler, D. Hebert, E. Harvey and C. Licht

    Version of Record online : 8 JUN 2012, DOI: 10.1111/j.1600-6143.2012.04124.x

  2. You have free access to this content
    Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort

    Internal Medicine Journal

    Volume 45, Issue 10, October 2015, Pages: 1054–1065, A. Mallett, P. Hughes, J. Szer, A. Tuckfield, C. Van Eps, S. B. Cambell, C. Hawley, J. Burke, J. Kausman, I. Hewitt, A. Parnham, S. Ford and N. Isbel

    Version of Record online : 1 OCT 2015, DOI: 10.1111/imj.12864

  3. You have free access to this content
    The use of eculizumab in renal transplantation

    Clinical Transplantation

    Volume 27, Issue 3, May/June 2013, Pages: E216–E229, A. Nicholas R. Barnett, Elham Asgari, Paramit Chowdhury, Steven H. Sacks, Anthony Dorling and Nizam Mamode

    Version of Record online : 21 MAR 2013, DOI: 10.1111/ctr.12102

  4. You have free access to this content
    Antibody-mediated rejection despite inhibition of terminal complement

    Transplant International

    Volume 27, Issue 12, December 2014, Pages: 1235–1243, Andrew Bentall, Dolly B. Tyan, Flavia Sequeira, Matthew J. Everly, Manish J. Gandhi, Lynn D. Cornell, Han Li, Nicole A. Henderson, Suresh Raghavaiah, Jeffrey L. Winters, Patrick G. Dean and Mark D. Stegall

    Version of Record online : 20 AUG 2014, DOI: 10.1111/tri.12396

  5. You have free access to this content
    Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

    American Journal of Transplantation

    Volume 12, Issue 12, December 2012, Pages: 3337–3354, J. Zuber, M. Le Quintrec, S. Krid, C. Bertoye, V. Gueutin, A. Lahoche, N. Heyne, G. Ardissino, V. Chatelet, L.-H. Noël, M. Hourmant, P. Niaudet, V. Frémeaux-Bacchi, E. Rondeau, C. Legendre, C. Loirat and the French Study Group for Atypical HUS

    Version of Record online : 7 SEP 2012, DOI: 10.1111/j.1600-6143.2012.04252.x

  6. You have free access to this content
    Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

    Clinical & Experimental Immunology

    Volume 187, Issue 2, February 2017, Pages: 304–315, C. Wehling, O. Amon, M. Bommer, B. Hoppe, K. Kentouche, G. Schalk, R. Weimer, M. Wiesener, B. Hohenstein, B. Tönshoff, R. Büscher, H. Fehrenbach, Ö.-N. Gök and M. Kirschfink

    Version of Record online : 25 NOV 2016, DOI: 10.1111/cei.12890

  7. Antibody-Mediated Rejection in Kidney Transplantation: A Review of Pathophysiology, Diagnosis, and Treatment Options

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 7, July 2014, Pages: 733–744, Miae Kim, Spencer T. Martin, Keri R. Townsend and Steven Gabardi

    Version of Record online : 19 APR 2014, DOI: 10.1002/phar.1426

  8. You have free access to this content
    Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

    British Journal of Haematology

    Volume 149, Issue 3, May 2010, Pages: 414–425, Anita Hill, Russell P. Rother, Xunde Wang, Sidney M. Morris, Jr, Kerry Quinn-Senger, Richard Kelly, Stephen J. Richards, Monica Bessler, Leonard Bell, Peter Hillmen and Mark T. Gladwin

    Version of Record online : 8 MAR 2010, DOI: 10.1111/j.1365-2141.2010.08096.x

  9. You have free access to this content
    Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale

    Transplant International

    Volume 25, Issue 6, June 2012, Pages: 623–632, Thomas Fehr and Ariana Gaspert

    Version of Record online : 6 MAR 2012, DOI: 10.1111/j.1432-2277.2012.01453.x

  10. You have free access to this content
    Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria

    Intervention Review

    The Cochrane Library

    Arturo J Martí-Carvajal, Vidhu Anand, Andrés Felipe Cardona and Ivan Solà

    Published Online : 30 OCT 2014, DOI: 10.1002/14651858.CD010340.pub2

  11. You have free access to this content
    Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

    British Journal of Haematology

    Volume 142, Issue 2, July 2008, Pages: 263–272, Jörg Schubert, Peter Hillmen, Alexander Röth, Neal S. Young, Modupe O. Elebute, Jeffrey Szer, Giacomo Gianfaldoni, Gérard Socié, Paul Browne, Robert Geller, Russell P. Rother and Petra Muus

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2141.2008.07183.x

  12. You have full text access to this OnlineOpen article
    Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

    British Journal of Haematology

    Volume 162, Issue 1, July 2013, Pages: 62–73, Peter Hillmen, Petra Muus, Alexander Röth, Modupe O. Elebute, Antonio M. Risitano, Hubert Schrezenmeier, Jeffrey Szer, Paul Browne, Jaroslaw P. Maciejewski, Jörg Schubert, Alvaro Urbano-Ispizua, Carlos de Castro, Gérard Socié and Robert A. Brodsky

    Version of Record online : 25 APR 2013, DOI: 10.1111/bjh.12347

  13. New Therapeutic Approaches to Antibody-Mediated Rejection in Renal Transplantation

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 310–315, S Raghavaiah and MD Stegall

    Version of Record online : 6 JUL 2011, DOI: 10.1038/clpt.2011.123

  14. You have free access to this content
    Renal Transplantation Under Prophylactic Eculizumab in Atypical Hemolytic Uremic Syndrome With CFH/CFHR1 Hybrid Protein

    American Journal of Transplantation

    Volume 12, Issue 7, July 2012, Pages: 1938–1944, S. Krid, LT. Roumenina, D. Beury, M. Charbit, O. Boyer, V. Frémeaux-Bacchi and P. Niaudet

    Version of Record online : 11 APR 2012, DOI: 10.1111/j.1600-6143.2012.04051.x

  15. Eculizumab dosing regimen in atypical HUS: Possibilities for individualized treatment

    Clinical Pharmacology & Therapeutics

    Accepted manuscript online: 15 MAR 2017, Elena Volokhina, Kioa Wijnsma, Renate van der Molen, Nel Roeleveld, Thea van der Velden, Joop Goertz, Fred Sweep, Roger J. Brüggemann, Jack Wetzels, Nicole van de Kar and Lambertus van den Heuvel

    DOI: 10.1002/cpt.686

  16. Treatment of antibody-mediated rejection in renal transplant patients: a clinical practice survey

    Clinical Transplantation

    Volume 29, Issue 2, February 2015, Pages: 118–123, Stephanie A. Burton, Naaseha Amir, Alaina Asbury, Alex Lange and Karen L. Hardinger

    Version of Record online : 4 JAN 2015, DOI: 10.1111/ctr.12491

  17. Paroxysmal Nocturnal Haemoglobinuria

    Postgraduate Haematology, Sixth edition

    A Victor Hoffbrand, Daniel Catovsky, Edward GD Tuddenham, Anthony R Green, Pages: 176–185, 2010

    Published Online : 16 NOV 2010, DOI: 10.1002/9781444323160.ch11

  18. You have free access to this content
    Eculizumab, Bortezomib and Kidney Paired Donation Facilitate Transplantation of a Highly Sensitized Patient Without Vascular Access

    American Journal of Transplantation

    Volume 10, Issue 9, September 2010, Pages: 2154–2160, B. E. Lonze, N. N. Dagher, C. E. Simpkins, J. E. Locke, A. L. Singer, D. L. Segev, A. A. Zachary and R. A. Montgomery

    Version of Record online : 15 JUL 2010, DOI: 10.1111/j.1600-6143.2010.03191.x

  19. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation

    Pediatric Transplantation

    Volume 18, Issue 6, September 2014, Pages: E185–E189, Daniel Ranch, Barrett Crowther, Mazen Arar and Chatchawin Assanasen

    Version of Record online : 14 JUN 2014, DOI: 10.1111/petr.12290

  20. Complement inhibition as potential new therapy for antibody-mediated rejection

    Transplant International

    Volume 29, Issue 4, April 2016, Pages: 392–402, Farsad Eskandary, Markus Wahrmann, Jakob Mühlbacher and Georg A. Böhmig

    Version of Record online : 10 NOV 2015, DOI: 10.1111/tri.12706